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The herpes simplex virus (HSV) is endemic and 90% of the world
population is seropositive. Although HSV is the most frequent virus
identiﬁed in patients with encephalitis, the incidence of HSV
encephalitis (HSE) is low with only 0.7–13.8 per 100,000 annually.
HSV-1 infection is ten times as frequent as cases of HSV-2 derived
HSE.
Early diagnosis and treatment of HSE is crucial for a good
outcome, however the clinical presentation is variable and
nonspeciﬁc. Untreated the mortality is as high as 70% and only
2.5% survive without any neurological deﬁcit. The reactivation of
HSE after neurosurgery is a very rare complication; few cases are
reported in the literature.1
2. Case report
A 25 year old woman, in other respects healthy, suffered from
epilepsy from the age of eight years. She, nor her parents, could
recall any cold sores or venereal disease, episodes of reduced
consciousness, and she had never been admitted to a hospital.
She typically experienced three to four epileptic attacks a month
of aura symptoms presenting with abdominal discomfort
spreading toward the head. Occasionally, she developed auto-
matisms and ﬁts that usually lasted for 2 min without loss of
consciousness. She had been treated with valproic acid,
lamotrigin, levetiracetam, etosuksimid and frisium with only* Corresponding author. Tel.: +47 936 47 946.
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EEG over 72 h revealed ictal epileptic activity starting in the left
medial temporal lobe. Cerebral MRI displayed reduced volume of
the left hippocampus and 18F-FDG PET showed reduced uptake
in the left medial temporal lobe. Selective intracarotid sodium
amobarbital injections (WADA-test) revealed a left-dominant
language function, and a bilateral, right sided dominant memory
function. After multidisciplinary assessment she was offered a
medial temporal lobe resection.
A left anterior temporal lobectomy with hippocampoamygda-
lectomy through the middle temporal gyrus was performed
without any intraoperative complications. On the third postoper-
ative day she developed headache, became lethargic and slightly
disoriented. She had no fever. A cerebral CT displayed the resected
region as expected, without any other abnormalities. At day eleven
she developed fever and increased headache with subsequent neck
stiffness and photophobia. Intravenous antibiotic treatment with
cloxacillin and ceftriaxone was started. Day eighteen after surgery
she developed dysphasia and right sided hemiparesis. Cerebral
MRI displayed hemorrhagic cortical infarction in the frontal and
remaining left temporal lobe. Acyclovir 10 mg/kg 3 was then
administered. HSV-2 was detected by real-time PCR of the CSF by
two separate DNA isolation procedures at the ﬁrst CSF sampling. In
the assay used (artus HSV-1/-2PCR kit, Qiagen) a cycle threshold
(Ct) value <35 is considered positive. The CSF sample had a Ct value
of 21.92, whereas positive controls for HSV-1 and -2 were 21.53
and 25.53, respectively. Speciﬁc identiﬁcation of HSV-2 was done
by melting point analysis. HSV-2 virus was also identiﬁed on a
second lumbar tap at day 18. HSV-1, human herpes virus-6,
Epstein-Bar virus, varcicella zoster virus and enterovirus qPCRs
were all negative.served.
Fig. 1. (A) FDG-PET CT cerebrum scans reduced metabolism in the left hippocampus (arrow). (B) FLAIR MRI showing reduced volume of the left hippocampus (arrow). (C) CT
cerebrum scan showing cerebral parenchymal microcalciﬁcations in the frontal and parietal lobes (arrows). (D) T2 cerebral MRI showing left temporal and frontal edema
characteristic for HSE. (E) Overview histological images showing small clusters of CD3-positive lymphocytes in hippocampus. (F) Hematoxylin–eosin staining consistent with
lymphocyte inﬁltration, conﬁrmed with CD3-positive staining for T-lymphocytes (G). Some CD68-positive microglia were found among the lymphocytes (H).
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one small aggregate of lymphocytes in the cortex of the lateral
temporal lobe. Similar accumulations of CD3 + CD20-lympho-
cytes were found in the hippocampus. A few microglia cells were
seen between the lymphocytes in a section immunostained for
CD68. The accumulations of lymphocytes did not have the typical
morphology of microglia nodules. No perivascular lymphocyte
accumulations were found. Findings were thus not in concor-
dance with classical viral encephalitic changes. Small foci of
gliosis were found in the hippocampus (Wyler score I).
Immunohistochemical staining for HSV-1, cytomegalovirus and
toxoplasmosis was negative. In situ hybridization for EBV and JC
virus was also negative. Retrospectively, re-evaluation of
preoperative cerebral CT scans displayed small areas of
calciﬁcation in the frontal regions.
At departure thirty-four days after surgery, her dysphasia and
right hemiparesis were improving. She was given acyclovir for aTable 1
Laboratory examinations.
Days after surgery 11 18
Blood sampling
C-reactive protein, mg/L 0.7 <0.6
Leukocytes, 109/L 7.3 6.8
CSF sampling
Leukocytes, 106/L 222 544
Protein, g/L 1.4 2.6total of four weeks. Twelve weeks after surgery she had recovered
to normal neurological status with the exception of mild
dysphasia, she had not experienced any epileptic seizures since
discharge (Engel class 1).
3. Discussion
Reactivation by mucocutaneous infection of latent HSV
infection is common, and was reported already by Harvey
Cushing. However, the pathway by which HSV reaches the brain
and causes encephalitis remains elusive. During primary
infection the virus probably gains access to the olfactory bulbs
and subsequently spreads along the olfactory pathway to
orbitofrontal and mesial temporal lobes.2 The high afﬁnity for
these speciﬁc areas is unknown, but may be due to close
proximity of dural nerves, through which the virus may travel
by cell to cell contact and across the meninges. Acute seizures
occur frequently (40–60%) in HSE, and also the risk of
developing late unprovoked seizures is high. The reason for
the epileptogenicity of HSV is unknown, but is probably related
to the propensity to involve the highly epileptogenic mesial
temporal and basal frontal lobes.3
HSE as a result of postoperative reactivation is rare.2 It is
uncertain whether HSE after neurosurgery is due to reactivation or
primary infection. Virus could be reactivated and spread from the
trigeminal or olfactorial ganglia, or occasionally HSV may be
identiﬁed in the brain. The presence of the established histological
lesions preoperatively supports a reactivation of virus to be the
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in three patients 3–10 years after HSE. In one of these three cases
HSV-1 DNA could be identiﬁed in biopsies.4
Our patient had no previous history of encephalitis. It is possible
that she could have had a subclinical infection, but the severity of
HSE, especially neonatally and untreated, makes this intriguing.
This is also, to our knowledge, the ﬁrst case of HSV2 reactivation
meningoencephalitis reported. Our case is of special interest as it
may provide information to several ongoing discussions: (i) the
high epileptogenicity of herpes virus is still enigmatic, (ii) why HSV
seem to have a high afﬁnity to the mesial temporal, and (iii)
whether there is an association between HSV infection and the
development of Mesial Temporal Lobe Epilepsy with Hippocampal
Sclerosis (MTLE-HS). Animal studies have shown that animals that
does not die of HSE after HSV inoculation, may survive with
hippocampal changes equivalent to hippocampal sclerosis (Fig. 1
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